Xiao-Zhou Mou

Dr. Xiao-Zhou Mou

Clinical Research Institute, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou 310014, China
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Cellular Immunology
Verified
Journal Article
Closed access
LFLuo-Qin Fu
Luo-Qin Fu
WDWen-Lin Du
Wen-Lin Du
MCMao-Hua Cai
Mao-Hua Cai
JYJia-Yu Yao
Jia-Yu Yao
YZYuan-Yuan Zhao
Yuan-Yuan Zhao
XMXiao-Zhou Mou
Xiao-Zhou Mou

8 October 2021 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
CCChangyu Cao
Changyu Cao
HZHai Zou
Hai Zou
NYNan Yang
Nan Yang
HLHui Li
Hui Li
YCYu Cai
Yu Cai
XDXiaochen Dong
Xiaochen Dong

18 July 2019 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
YWYing Wang
Ying Wang
WCWanyuan Chen
Wanyuan Chen
JLJiayan Lian
Jiayan Lian
HZHaibo Zhang
Haibo Zhang
BYBo Yu
Bo Yu
JTJianming Tang
Jianming Tang
Long noncoding RNAs (lncRNAs) play important roles in regulating the development and progression of many cancers. However, the clinical significance of specific lncRNAs in the context of nasopharyngeal carcinoma (NPC) and the molecular mechanisms by which they regulate this form of cancer remain largely unclear. In this study we found that the lncRNA PVT1 was upregulated in NPC, and that in patients this upregulation was associated with reduced survival. RNA sequencing revealed that PVT1 was responsible for regulating NPC cell proliferation and for controlling a hypoxia-related phenotype in these cells. PVT1 knockdown reduced NPC cell proliferation, colony formation, and tumorigenesis in a subcutaneous mouse xenograft model systems. We further found that PVT1 serves as a scaffold for the chromatin modification factor KAT2A, which mediates histone 3 lysine 9 acetylation (H3K9), recruiting the nuclear receptor binding protein TIF1β to activate NF90 transcription, thereby increasing HIF-1α stability and promoting a malignant phenotype in NPC cells. Overexpression of NF90 or HIF-1α restored the proliferation in cells that had ceased proliferating due to PVT1 or KAT2A depletion. Conversely, overexpression of active KAT2A or TIF1β, but not of KAT2A acetyltransferase activity-deficient mutants or TIF1β isoforms lacking H3K9ac binding sites, promoted a PVT1-mediated increase in NF90 transcription, as well as increased HIF-1α stability and cell proliferation. PVT1 knockdown enhanced the radiosensitization effect in NPC cells via inhibiting binding between H3K9ac and TIF1β in a manner. Taken together, our results demonstrate that PVT1 serves an oncogenic role and plays an important role in radiosensitivity in malignant NPC via activating the KAT2A acetyltransferase and stabilizing HIF-1α.

1 August 2021 in Biomaterials
Verified
Journal Article
Closed access
NYNan Yang
Nan Yang
HGHeng Guo
Heng Guo
CCChangyu Cao
Changyu Cao
XWXiaorui Wang
Xiaorui Wang
XSXuejiao Song
Xuejiao Song
XDXiaochen Dong
Xiaochen Dong

17 February 2021 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
MCMao-Hua Cai
Mao-Hua Cai
XCXiao-Yi Chen
Xiao-Yi Chen
LFLuo-Qin Fu
Luo-Qin Fu
WDWen-Lin Du
Wen-Lin Du
XYXue Yang
Xue Yang
PHPei-Yang Hu
Pei-Yang Hu
The applications of hydrogels in biomedical field has been since multiple decades. Discoveries in biology and chemistry render this platform endowed with much engineering potentials and growing continuously. Novel approaches in constructing these materials have led to the production of complex hybrid hydrogels systems that can incorporate both natural and synthetic polymers and other functional moieties for mediated cell response, tunable release kinetic profiles, thus they are used and research for diverse biomedical applications. Recent advancement in this field has established promising techniques for the development of biorelevant materials for construction of hybrid hydrogels with potential applications in the delivery of cancer therapeutics, drug discovery, and re-generative medicines. In this review, recent trends in advanced hybrid hydrogels systems incorporating nano/microstructures, their synthesis, and their potential applications in tissue engineering and anticancer drug delivery has been discussed. Examples of some new approaches including click reactions implementation, 3D printing, and photopatterning for the development of these materials has been briefly discussed. In addition, the application of biomolecules and motifs for desired outcomes, and tailoring of their transport and kinetic behavior for achieving desired outcomes in hybrid nanogels has also been reviewed.

1 January 2021 in Theranostics
Verified
Journal Article
Open access
CJChangwei Ji
Changwei Ji
JSJingxing Si
Jingxing Si
YXYan Xu
Yan Xu
WZWenjing Zhang
Wenjing Zhang
YYYaqian Yang
Yaqian Yang
HGHongqian Guo
Hongqian Guo
Background: Sonodynamic therapy (SDT) is a promising strategy to inhibit tumor growth and activate antitumor immune responses for immunotherapy. However, the hypoxic and immunosuppressive tumor microenvironment limits its therapeutic efficacy and suppresses immune response.